FDA Flags High-Risk Recall: Hologic’s BioZorb Markers Under Scrutiny

The US FDA has labeled Hologic’s BioZorb Markers recall as Class I high-risk, highlighting safety concerns about devices cleared via the 510(k) pathway. The recall is due to reports of adverse events tied to the radiographic markers.